Printer Friendly

ARGENTINA APPROVES APPLIED BIOSYSTEMS' VIROSEQ KIT.

Applied Biosystems (NYSE: PEB), Foster City, Calif., a PE Corporation business, has announced that the Argentine Ministry of Health has approved the sale of the ViroSeq(tm) HIV-1 Genotyping System Version 2 for diagnostic purposes. It is the first HIV-1 genotyping system to receive such approval in Argentina. This authorization grants to BioSystems SA -- Applied Biosystems distributor in Argentina -- the right to market the ViroSeq system to reference laboratories for the management of HIV-1 therapies Argentina is the first country to authorize the system for clinical use ; similar approval by other South American countries is expected soon.

The Ministry of Health granted its approval after subjecting the ViroSeq system to rigorous validation tests, conducted by Drs. Jorge Benetucci and Juan Carlos Garberi at the Foundation for the Study of Immunodeficiency. The Foundation is an affiliate of Hospital General de Infecciosos F. J. Muniz , a reference hospital in Argentina dedicated to infectious diseases. Clinicians there will use the ViroSeq system to conduct in vitro studies of the HIV-1 virus.

According to Stan Weinstein, senior marketing manager for molecular diagnostics, "This action by the Ministry of Health in Buenos Aires opens up an important market for us. We have always believed that the ViroSeq system is a valuable tool in the war against HIV-1, and we are extremely pleased that the Argentine government has approved our application."

A pioneer and market leader in the development and manufacture of automated systems for life science research, Applied Biosystems is also becoming a market leader in the emerging field of molecular diagnostics. It hopes eventually to establish its HIV-1 genotyping system as an important diagnostic tool in clinical laboratories around the world.

The ViroSeq system is currently marketed in the US as a Research-Use-Only ( RUO) product. Applied Biosystems is diligently working for FDA authorization to market the ViroSeq system in the US for In Vitro Diagnostics (IVD) use

About PE Corporation

PE Corporation comprises two operating groups. The PE Biosystems Group, now conducting business under the Applied Biosystems name, develops and market s instrument-based systems, reagents, software and contract services to the life science industry and research community. Applied Biosystems is headquartered in Foster City, Calif. and reported sales of $1.4 billion during fiscal 2000. The Celera Genomics Group (NYSE: CRA), headquartered in Rockville, Md., intends to become the definitive source of genomic and related medical information. Visit http://www.pecorporation.com or call 800.762.6923.

For more information, call 800.345.5224 or 650.638.6443 or visit http://www.appliedbiosystems.com.
COPYRIGHT 2001 Worldwide Videotex
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Worldwide Biotech
Date:Jan 1, 2001
Words:420
Previous Article:HIGHER DOSES OF INTERFERON BETA-1A GIVE NO ADDED BENEFIT.
Next Article:AUSTRALIA APPROVES CARDIAC SCIENCES' POWERHEART.
Topics:


Related Articles
APPLIED BIOSYSTEMS/BRAZILIAN NMH SIGN PACT FOR GENOTYPING.
Applied Science: Brazil has its AIDS epidemic nearly cornered. Genetic sleuthing could help seal the deal. (Genetics).

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters